CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-25 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −49,832 | $8.26 | $412K | 223,168 |
| 2021-04-25 | BOLL ANDREW R. Chief Financial Officer | Option exercise · Restricked Stock Unit | −127,500 | 0 | ||
| 2021-04-25 | BAUM MARK L Chief Executive Officer | Option exercise | +850,000 | 1,687,676 | ||
| 2021-04-25 | BAUM MARK L Chief Executive Officer | Shares withheld for taxes | −334,129 | $8.26 | $2.8M | 1,353,547 |
| 2021-04-25 | BAUM MARK L Chief Executive Officer | Option exercise · Restricked Stock Unit | −850,000 | 0 | ||
| 2021-02-25 | BAUM MARK L Chief Executive Officer | Option exercise | +200,000 | 837,676 | ||
| 2021-02-25 | BAUM MARK L Chief Executive Officer | Option exercise · Restricted Stock Unit | −200,000 | 850,000 | ||
| 2021-02-25 | BOLL ANDREW R. Chief Financial Officer | Option exercise | +30,000 | 153,000 | ||
| 2021-02-25 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −7,500 | $7.68 | $58K | 145,500 |
| 2021-02-25 | BOLL ANDREW R. Chief Financial Officer | Option exercise · Restricted Stock Unit | −30,000 | 127,500 | ||
| 2021-02-19 | SAHAREK JOHN P. President, ImprimisRx | Grant or award · Restricted Stock Unit | +30,000 | 30,000 | ||
| 2021-02-19 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Restricted Stock Unit | +45,000 | 45,000 | ||
| 2021-02-19 | BAUM MARK L Chief Executive Officer | Grant or award · Restricted Stock Unit | +150,000 | 150,000 | ||
| 2020-12-22 | Opaleye Management Inc. 10% owner | Purchase | +15,900 | $5.19 | $83K | 2,929,400 |
| 2020-12-22 | Opaleye Management Inc. 10% owner | Purchase | +657 | $5.19 | $3K | 136,016 |
| 2020-12-21 | Opaleye Management Inc. 10% owner | Purchase | +51,400 | $5.24 | $269K | 2,913,500 |
| 2020-12-21 | Opaleye Management Inc. 10% owner | Purchase | +2,059 | $5.24 | $11K | 135,359 |
| 2020-12-18 | Opaleye Management Inc. 10% owner | Purchase | +35,000 | $5.31 | $186K | 2,862,100 |
| 2020-12-18 | Opaleye Management Inc. 10% owner | Purchase | +1,400 | $5.31 | $7K | 133,300 |
| 2020-09-28 | Principi Anthony Director | Option exercise | +93,798 | 93,798 |
Page 10 of 17 · 336 trades